These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19481806)

  • 1. Trimeric coiled-coil domain of human pulmonary surfactant protein D enhances zinc-binding ability and biologic activity of soluble TRAIL.
    Wu X; Li P; Qian C; Li O; Zhou Y
    Mol Immunol; 2009 Jul; 46(11-12):2381-8. PubMed ID: 19481806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducing rigid local structure around the zinc-binding region by hydrophobic interactions enhances the homotrimerization and apoptotic activity of zinc-free TRAIL.
    Lee HW; Kim TI; Chan KH; Kwon MH; Kim JS; Jin M; Kim YS
    Biochem Biophys Res Commun; 2007 Oct; 362(3):766-72. PubMed ID: 17765202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of expression level and bioactivity of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) by a novel zinc ion feeding strategy.
    Sun AY; Shen YL; Yin JC; Zhang H; Tang YN; Wei DZ
    Biotechnol Lett; 2006 Aug; 28(15):1215-9. PubMed ID: 16799759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pVAX1 plasmid vector-mediated gene transfer of soluble TRAIL suppresses human hepatocellular carcinoma growth in nude mice.
    Zhang Y; Ma CH; Liu H; Zhang XM; Sun WS
    Acta Biochim Pol; 2007; 54(2):307-13. PubMed ID: 17546204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C repeats of the streptococcal M1 protein achieve the human serum albumin binding ability by flanking regions which stabilize the coiled-coil conformation.
    Gubbe K; Misselwitz R; Welfle K; Reichardt W; Schmidt KH; Welfle H
    Biochemistry; 1997 Jul; 36(26):8107-13. PubMed ID: 9201959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior serum half life of albumin tagged TNF ligands.
    Müller N; Schneider B; Pfizenmaier K; Wajant H
    Biochem Biophys Res Commun; 2010 Jun; 396(4):793-9. PubMed ID: 20447380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
    Ma H; Liu Y; Liu S; Xu R; Zheng D
    Hepatology; 2005 Dec; 42(6):1355-63. PubMed ID: 16317690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and physicochemical evaluation of the conformational stability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Youn YS; Shin MJ; Chae SY; Jin CH; Kim TH; Lee KC
    Biotechnol Lett; 2007 May; 29(5):713-21. PubMed ID: 17318333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Lin Z; Lei H; Cao P
    Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L.
    Berg D; Lehne M; Müller N; Siegmund D; Münkel S; Sebald W; Pfizenmaier K; Wajant H
    Cell Death Differ; 2007 Dec; 14(12):2021-34. PubMed ID: 17703232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.
    Cordier F; Vinolo E; Véron M; Delepierre M; Agou F
    J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific PEGylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL).
    Pan LQ; Wang HB; Lai J; Xu YC; Zhang C; Chen SQ
    Biomaterials; 2013 Dec; 34(36):9115-23. PubMed ID: 23981355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-ion-dependent GFP emission in vivo by combining a circularly permutated green fluorescent protein with an engineered metal-ion-binding coiled-coil.
    Mizuno T; Murao K; Tanabe Y; Oda M; Tanaka T
    J Am Chem Soc; 2007 Sep; 129(37):11378-83. PubMed ID: 17722917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.
    Moriwaki K; Noda K; Furukawa Y; Ohshima K; Uchiyama A; Nakagawa T; Taniguchi N; Daigo Y; Nakamura Y; Hayashi N; Miyoshi E
    Gastroenterology; 2009 Jul; 137(1):188-98, 198.e1-2. PubMed ID: 19361506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye.
    Secchiero P; Lamberti G; Corallini F; Melloni E; Guarnotta C; Sebastiani A; Zauli G
    J Cell Physiol; 2009 Jan; 218(1):199-204. PubMed ID: 18780288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma.
    Lamoureux F; Picarda G; Garrigue-Antar L; Baud'huin M; Trichet V; Vidal A; Miot-Noirault E; Pitard B; Heymann D; Rédini F
    Cancer Res; 2009 Jan; 69(2):526-36. PubMed ID: 19147566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.
    Mahajan L; Madan T; Kamal N; Singh VK; Sim RB; Telang SD; Ramchand CN; Waters P; Kishore U; Sarma PU
    Int Immunol; 2008 Aug; 20(8):993-1007. PubMed ID: 18628238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.